Traws Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Traws Pharma, Inc. (TRAW) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-14
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Traws Pharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 24 month |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | 0.00% 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | 0.00% 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-15 | ||||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-15 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | 0.00% 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-30 | 0.00% 10-K · filed 2022-03-21 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | 0.00% 10-K · filed 2021-03-18 | ||||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-16 | ||||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-12 | ||||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-18 | ||||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-27 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |